Prion disease is an excellent candidate for this approach, since simply decreasing PrP expression will have a therapeutic effect (2) and the human PRNP promoter contains a large annotated CpG island to serve as a substrate for DNA methylation. This evidence concerns the gene PRNP and prion disease.